Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-01-05 @ 5:55 PM
Study NCT ID:
NCT05995392
Status:
UNKNOWN
Last Update Posted:
2023-08-21
First Post:
2023-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease
Sponsor:
Richard W Yee, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-04
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-09
First Submit QC Date:
None
Study First Post Date:
2023-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-16
Last Update Post Date:
2023-08-21
Last Update Post Date Type:
ACTUAL